Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000799208 | SCV000938862 | pathogenic | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with Usher's syndrome type II (PMID: 28653555, 30073356). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 645172). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln2862*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). |
Baylor Genetics | RCV003461113 | SCV004208212 | pathogenic | Retinitis pigmentosa 39 | 2023-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000799208 | SCV005201215 | pathogenic | not provided | 2023-12-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28653555, 32675063, 33089500, 33535592, 30073356) |